Hyundai Pharmaceutical Co., Ltd. (004310.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.3x

Market Cap

KRW 201.28B

MomentumView details →

1D Return

+1.45%

YTD Return

−6.69%

RSI (14)

66.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.3x

Market Cap

KRW 201.28B

RSI (14)

66.0

MomentumView details →

1D Return

+1.45%

YTD Return

−6.69%

ProfitabilityView details →

Gross Margin

35.83%

Net Margin

2.20%

EBITDA Margin

5.65%

ROE (TTM)

3.47%

ROA (TTM)

1.98%

Asset Turnover

0.90x

GrowthView details →

Revenue YoY

+12.04%

EPS YoY

+310.58%

FCF YoY

+97.68%

Revenue CAGR 3Y

+5.64%

EPS CAGR 3Y

−34.70%

EBITDA YoY

+566.71%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.39x

Current Ratio

1.69x

Quick Ratio

1.10x

Div Yield

0.39%

Div Rate

KRW 30.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

202.33B

Net Income (TTM)

4.44B

Op. CF (TTM)

3.21B

Latest newsMore news →

No recent news for 004310.KS.

Similar companies

Yungjin Pharm. Co., Ltd.003520.KS Whan In Pharm Co.,Ltd.016580.KS Boditech Med Inc.206640.KQ Hansoh Pharmaceutical Group Company Limited03692.HK REYON Pharmaceutical Co., Ltd.102460.KS AptaBio Therapeutics Inc.293780.KQ Find similar companies →

Latest newsMore news →

No recent news for 004310.KS.